Diagnostic markers for glaucoma: a patent and literature review (2013-2019)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 18, 2019 Category: Drugs & Pharmacology Authors: Silvia Bua Claudiu T Supuran Source Type: research

Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013 –2019)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 9, 2019 Category: Drugs & Pharmacology Authors: Alessio Nocentini Claudiu T. Supuran Source Type: research

Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 – 2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 4, 2019 Category: Drugs & Pharmacology Authors: Andrea Angeli Claudiu T Supuran Source Type: research

Novel method of treating macular degeneration: a patent evaluation (WO2018/107005)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 1, 2019 Category: Drugs & Pharmacology Authors: Clemente Capasso Jean-Yves Winum Source Type: research

Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 23, 2019 Category: Drugs & Pharmacology Authors: Alessandro Bonardi Claudiu T Supuran Source Type: research

Retinoic acid receptor-related orphan receptor gamma-t (ROR γt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 19, 2019 Category: Drugs & Pharmacology Authors: Nannan Sun Huimin Guo Yonghui Wang Source Type: research

Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 14, 2019 Category: Drugs & Pharmacology Authors: Hidayat Hussain Ivan R Green Ghulam Abbas Sergazy M Adekenov Wahid Hussain Iftikhar Ali Source Type: research

Novel therapies for glaucoma: a patent review (2013-2019)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 11, 2019 Category: Drugs & Pharmacology Authors: Paolo Guglielmi Simone Carradori Cristina Campestre Giovanna Poce Source Type: research

Combretastatin-based compounds with therapeutic characteristics: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 9, 2019 Category: Drugs & Pharmacology Authors: Lalit Mohan Nainwal Mohammad Mumtaz Alam Mohammad Shaquiquzzaman Akranth Marella Ahmed Kamal Source Type: research

A patent review of RAF kinase inhibitors (2010 –2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 7, 2019 Category: Drugs & Pharmacology Authors: Ruo-Jun Man Ya-Liang Zhang Ai-Qin Jiang Hai-Liang Zhu Source Type: research

Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 4, 2019 Category: Drugs & Pharmacology Authors: Kashif Haider Shaik Rahaman M Shahar Yar Ahmed Kamal Source Type: research

Therapeutic potential of seabuckthorn: a patent review (2000-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 1, 2019 Category: Drugs & Pharmacology Authors: Inder Pal Singh Furkan Ahmad Dattatraya Dinkar Gore Kulbhushan Tikoo Arvind Bansal Sanjay Madhukar Jachak Gopabandhu Jena Source Type: research

Therapeutic modulation of retinoid X receptors – SAR and therapeutic potential of RXR ligands and recent patents
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 22, 2019 Category: Drugs & Pharmacology Authors: Simone Schierle Daniel Merk Source Type: research

LAG-3 antagonists by cancer treatment: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 18, 2019 Category: Drugs & Pharmacology Authors: Martin Perez-Santos Maricruz Anaya-Ruiz Jorge Cebada Cindy Bandala Gerardo Landeta Patricia Mart ínez-Morales Nemesio Villa-Ruano Source Type: research

Drug prices and trends before and after requesting compulsory licenses: the Ecuadorian experience
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 17, 2019 Category: Drugs & Pharmacology Authors: Esteban Ortiz-Prado Gabriel Cevallos-Sierra Enrique Teran Eduardo Vasconez Daniel Borrero-Maldonado Jorge Ponce Zea Katherine Simba ña-Rivera Lenin G ómez-Barreno Source Type: research

A patent review of BRAF inhibitors: 2013-2018
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 13, 2019 Category: Drugs & Pharmacology Authors: Peng-Fei Wang Han-Yue Qiu Hai-Liang Zhu Source Type: research

Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Authors: Irma Herrera-Camacho Maricruz Anaya-Ruiz Martin Perez-Santos Lourdes Mill án-Pérez Peña Cindy Bandala Gerardo Landeta Source Type: research

Correction
Volume 29, Issue 7, July 2019, Page 579-585 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Source Type: research

mGluR2 positive allosteric modulators: an updated patent review (2013 –2018)
Volume 29, Issue 7, July 2019, Page 497-507 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Authors: Andr és A Trabanco Jos é Manuel Bartolomé Jos é María Cid Source Type: research

Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Authors: Irma Herrera-Camacho Maricruz Anaya-Ruiz Martin Perez-Santos Lourdes Mill án-Pérez Peña Cindy Bandala Gerardo Landeta Source Type: research

Correction
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Source Type: research

mGluR2 positive allosteric modulators: an updated patent review (2013 –2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 4, 2019 Category: Drugs & Pharmacology Authors: Andr és A Trabanco Jos é Manuel Bartolomé Jos é María Cid Source Type: research

Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 26, 2019 Category: Drugs & Pharmacology Authors: Hidayat Hussain Ghulam Abbas Ivan R. Green Iftikhar Ali Source Type: research

Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 22, 2019 Category: Drugs & Pharmacology Authors: Martin Perez-Santos Maricruz Anaya-Ruiz Irma Herrera-Camacho Lourdes Mill án-Pérez Peña Source Type: research

Carbonic anhydrases as disease markers
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 18, 2019 Category: Drugs & Pharmacology Authors: Sabina Zamanova Ahmed M Shabana Utpal K Mondal Marc A Ilies Source Type: research

A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 17, 2019 Category: Drugs & Pharmacology Authors: L Crocetti MT Quinn IA Schepetkin MP Giovannoni Source Type: research

A literature review of the patent publications on venetoclax – a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 8, 2019 Category: Drugs & Pharmacology Authors: Nina Žigart Zdenko Časar Source Type: research

A patent review of FGFR4 selective inhibition in cancer (2007-2018)
Volume 29, Issue 6, June 2019, Page 429-438 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 31, 2019 Category: Drugs & Pharmacology Authors: Alvaro Quintanal-Villalonga Irene Ferrer Sonia Molina-Pinelo Luis Paz-Ares Source Type: research

A patent review of FGFR4 selective inhibition in cancer (2007-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 31, 2019 Category: Drugs & Pharmacology Authors: Alvaro Quintanal-Villalonga Irene Ferrer Sonia Molina-Pinelo Luis Paz-Ares Source Type: research

Therapeutic and cosmetic applications of mangiferin: an updated patent review (patents published after 2013)
Volume 29, Issue 6, June 2019, Page 463-479 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 29, 2019 Category: Drugs & Pharmacology Authors: Farha Quadri Manasi Telang Anita Mandhare Source Type: research

Therapeutic and cosmetic applications of mangiferin: an updated patent review (patents published after 2013)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 29, 2019 Category: Drugs & Pharmacology Authors: Farha Quadri Manasi Telang Anita Mandhare Source Type: research

Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
Volume 29, Issue 6, June 2019, Page 407-427 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 28, 2019 Category: Drugs & Pharmacology Authors: Sayyed Mohammad Ismail Mahboubi Rabbani Afshin Zarghi Source Type: research

Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 28, 2019 Category: Drugs & Pharmacology Authors: Sayyed Mohammad Ismail Mahboubi Rabbani Afshin Zarghi Source Type: research

Androgen receptor modulators: a review of recent patents and reports (2012-2018)
Volume 29, Issue 6, June 2019, Page 439-453 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 20, 2019 Category: Drugs & Pharmacology Authors: Shinya Fujii Hiroyuki Kagechika Source Type: research

An updated patent review on P-glycoprotein inhibitors (2011-2018)
Volume 29, Issue 6, June 2019, Page 455-461 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 18, 2019 Category: Drugs & Pharmacology Authors: Marcello Leopoldo Patrizia Nardulli Marialessandra Contino Francesco Leonetti Gert Luurtsema Nicola Antonio Colabufo Source Type: research

Androgen receptor modulators: a review of recent patents and reports (2012-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 16, 2019 Category: Drugs & Pharmacology Authors: Shinya Fujii Hiroyuki Kagechika Source Type: research

An updated patent review on P-glycoprotein inhibitors (2011-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 11, 2019 Category: Drugs & Pharmacology Authors: Marcello Leopoldo Patrizia Nardulli Marialessandra Contino Francesco Leonetti Gert Luurtsema Nicola Antonio Colabufo Source Type: research

MYC modulators in cancer: a patent review
Volume 29, Issue 5, May 2019, Page 353-367 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 9, 2019 Category: Drugs & Pharmacology Authors: Xiao-Na Wang Xiao-Xuan Su Sui-Qi Cheng Zhi-Yin Sun Zhi-Shu Huang Tian-Miao Ou Source Type: research

MYC modulators in cancer: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 9, 2019 Category: Drugs & Pharmacology Authors: Xiao-Na Wang Xiao-Xuan Su Sui-Qi Cheng Zhi-Yin Sun Zhi-Shu Huang Tian-Miao Ou Source Type: research

Effects of boron-containing compounds on immune responses: review and patenting trends
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 8, 2019 Category: Drugs & Pharmacology Authors: Karla S. Romero-Aguilar Ivonne M. Arciniega-Mart ínez Eunice D. Farf án-García Rafael Campos-Rodr íguez Aldo A. Res éndiz-Albor Marvin A. Soriano-Urs úa Source Type: research

An updated patent review of therapeutic applications of chalcone derivatives (2014-present)
Volume 29, Issue 5, May 2019, Page 385-406 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 29, 2019 Category: Drugs & Pharmacology Authors: Debarshi Kar Mahapatra Vivek Asati Sanjay Kumar Bharti Source Type: research

An updated patent review of therapeutic applications of chalcone derivatives (2014-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 29, 2019 Category: Drugs & Pharmacology Authors: Debarshi Kar Mahapatra Vivek Asati Sanjay Kumar Bharti Source Type: research

A patent review of bisphosphonates in treating bone disease
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 26, 2019 Category: Drugs & Pharmacology Authors: Sarah A. Holstein Source Type: research

SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 26, 2019 Category: Drugs & Pharmacology Authors: Jyotsana Pandey Akhilesh K Tamrakar Source Type: research